Abstract:Abstract Orbital or periorbital volume loss may be due to factors other than aging. Any sinister, progressive, or reversible etiology should be identified and addressed prior to embarking upon volume replacement. Injectable soft-tissue fillers offer titratable volume augmentation, precise soft-tissue placement, the ability to be performed in the office, biocompati-bility, low down-time, minimal morbidity, high safety and, in most cases, potential reversibility. The two main types of injectable soft-tissue fillers are collagen and stabilized hyaluronic acid. The latter can be instantly dissolved using hyaluroni-dase. Nonanimal stabilized hyaluronic acid fillers are the most commonly used in orbital and periorbital volume augmentation. Fillers with larger particle size have increased viscos-ity reduced ease of injection and increased duration. On average, a medium viscosity hyaluronic acid gel will last a year when injected in a pre-periosteal plane in the periorbital region or in the orbit. Soft-tissue fillers have been successfully used for volume augmentation in the orbit (both sighted and anophthalmic), the tear trough, the upper eyelid/sub-brow region and in the brow and temple region. 2 ml of hyaluronic acid filler, administered to the orbit via an inferotemporal peribulbar injection and placed posterior to the equator of the globe or implant, usually reduces enophthalmos by up to 2 mm and restores the signs of periorbital volume deficiency. A serial-puncture technique, with deep pre-periosteal placement of small aliquots of filler, followed by molding and massage of the gel, is recommended for filling in periorbital region. Typical side effects of periorbital filler injection include bruising and mild swelling, although these usually resolve within a few days and can be concealed with make-up or glasses. Lumpiness can be a problem in a minority of patients but usually settles. Persistent lumpiness can be corrected with further molding, additional filler or, in the case of hyaluronic acid fillers, dissolution with hyaluronidase. Patient satisfaction following periorbital soft- tissue filler for rejuvenation is between 80–95%. The role of injectable soft-tissue fillers in treating periorbital pathology is continuing to expand, with reports of their successful use in treating paralytic lagophthalmos, lower eyelid retraction and cicatricial ectropion.

Eyelid and Periorbital Dermal Fillers: Products, Techniques, and Outcomes

Non-surgical Volume Enhancement with Fillers in the Orbit and Periorbital Tissues: Cosmetic and Functional Considerations

Infraorbital Hollow Rejuvenation: Considerations, Complications, and the Contributions of Midface Volumization

A Periorbital Treatment Option Using a Polycaprolactone-based Dermal Filler for Infraorbital Volume Restoration: Case Series

Dermal Fillers for the Treatment of Tear Trough Deformity: A Review of Anatomy, Treatment Techniques, and their Outcomes

Periorbital injectables: Understanding and avoiding complications

Dermal Fillers for Tear Trough Rejuvenation: A Systematic Review

Fat or fillers: The dilemma in eyelid surgery

Bridging the Gap Rather Than Filling the Entire Valley-Anatomic Insights When Treating the Medial Infraorbital Region

Mild Complications or Unusual Persistence of Porcine Collagen and Hyaluronic Acid Gel Following Periocular Filler Injections

Applied Anatomy of Human Periobital Region

Classificação etiopatogênica de olheiras e preenchimento com ácido hialurônico: descrição de uma nova técnica utilizando cânula

The role of oculoplastic surgeons in minimally invasive cosmetic injectables

Nonsurgical Treatments for Infraorbital Rejuvenation: A Review

Tear trough rejuvenation using Restylane Eyelight

Selecting the Best Eyelid Techniques

Infraorbital Rejuvenation Combined with Thread-Lifting and Non-cross-linked Hyaluronic Acid Injection: A Retrospective, Case-Series Study

Hyaluronic Acid Filler for Forehead, Temporal, and Periorbicular Regions

Late onset periorbital edema in patients with a history of facial hyaluronic acid injection: A review on diagnosis and management

Application of infraorbital rim augmentation with pocket fat filling to correct tear trough deformity

Filler Migration to the Orbit